01-11-2020 | Parkinson's Disease | Letter to the Editor
Levodopa-carbidopa intestinal gel is an option in Parkinson’s disease with hyponatremia induced by dopamine agonists
Published in: Neurological Sciences | Issue 11/2020
Login to get access01-11-2020 | Parkinson's Disease | Letter to the Editor
Published in: Neurological Sciences | Issue 11/2020
Login to get access